MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
AZTA stock logo

AZTA

Azenta, Inc.

$22.72
0.01
 (0.04%)
Exchange:  NASDAQ
Market Cap:  1.047B
Shares Outstanding:  4.688M
Delayed data
Calculate AZTA Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Instruments & Supplies
   
CEO:  John Marotta
Full Time Employees:  3000
Address: 
15 Elizabeth Drive
Burlington
MA
1824
US
Website:  https://www.azenta.com
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company’s operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/02/04 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue665,072573,448593,821
Gross Profit233,256254,622270,280
EBITDA55,15171,61954,066
Operating Income-82,198-29,981-11,268
Net Income-14,257-164,897-55,763

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,885,7202,100,0412,059,582
Total Liabilities351,220331,074332,596
Total Stockholders Equity2,534,5001,768,9671,726,986
Total Debt60,43670,67651,244
Cash and Cash Equivalents678,910310,929279,783

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow17,49050,28972,181
Capital Expenditure-39,436-37,392-33,857
Free Cash Flow-21,94612,89738,324
Net Income-14,257-164,170-59,503
Net Change in Cash-357,251-363,055-24,305

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)729,376.149Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)746,991.109Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)742,800Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)127,750.247Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)130,835.507Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)130,101.435Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)78,879.162Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)81,369.479Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)80,776.961Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)300,985.848Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)308,254.874Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)306,525.362Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)1.760Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)1.770Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)1.720Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
656.323M  ?P/S
 (TTM)
: 
1.75
?Net Income
 (TTM)
: 
-164170000  ?P/E
 (TTM)
: 
-5.87
?Enterprise Value
 (TTM)
: 
867.524M  ?EV/FCF
 (TTM)
: 
30.21
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.11  ?ROIC
 (TTM)
: 
-0.01
?Net Debt
 (TTM)
: 
-411184000  ?Debt/Equity
 (TTM)
: 
0.04
?P/B
 (TTM)
: 
0.67  ?Current Ratio
 (TTM)
: 
2.83

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
50.49Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates AZTA intrinsic value between $3.57 – $3.61 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about AZTA valuation

Is Azenta, Inc. (AZTA) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Azenta, Inc. (AZTA) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is AZTA a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AZTA trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is AZTA’s P/E ratio?

You can see AZTA’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for AZTA?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is AZTA a good long-term investment?

Whether AZTA fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

AZTA

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.04
MARKETSnap

Trading Metrics:

Open: 23.02   Previous Close: 22.71
Day Low: 22.25   Day High: 23.41
Year Low: 15.93   Year High: 41.73
Price Avg 50: 21.98   Price Avg 200: 28.96
Volume: 955627   Average Volume: 1.181M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
14-05-2026 20:15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Azenta Inc (AZTA) Stock Up 5.4% and Still Undervalued -- GF Score: 72/100
28-05-2026 21:19
Azenta Inc (AZTA) Stock Up 5.4% and Still Undervalued -- GF Score: 72/100
Investors in Azenta, Inc. (AZTA) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
25-05-2026 00:10
Investors in Azenta, Inc. (AZTA) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
22-05-2026 17:00
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
22-05-2026 15:00
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
22-05-2026 13:21
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read